The heme oxygenase-1 (HO-1) enzyme system remains an attractive therapeutic target for
the treatment of inflammatory conditions. HO-1, a cellular stress protein, serves a vital …

Bilirubin is the end product of heme catabolism formed during a process that involves
oxidation-reduction reactions and conserves iron body stores. Unconjugated …

The potential for genetic variation to modulate neonatal hyperbilirubinemia risk is
increasingly being recognized. A case-control study was designed to assess comprehensive …

Objective To identify the association between UGT1A1 Gly71Arg and TATA promoter
polymorphisms and neonatal hyperbilirubinemia. Methods The studies related to the …

To date, the genetic risk factors for neonatal hyperbilirubinemia remain unknown in
Southeastern China. This case‐control study aimed to identify the genetic risk factors for …

Prolonged jaundice is a commonly evaluated condition. The aim of this study was to assess
the risk factors of jaundice in healthy infants at one month of age. This prospective cohort …

Background Hyperbilirubinemia is a common disorder during neonatal period in Taiwan.
Gene variants may play an important role in the development of neonatal …

In an infant's body, all the systems undergo significant changes in order to adapt to the new,
extrauterine environment and challenges which it poses. Fragile homeostasis can be easily …

Abstract Objective: The associations between Gly71Arg polymorphism in the coding region
of uridine diphosphate glucuronosyl transferase 1A1 (UGT1A1) gene and the risk of …

Several studies have shown that subjects with higher serum bilirubin may have a lower risk
of cardiovascular disorders. We herein investigated whether serum bilirubin concentration is …